Tottori Univ Oncolytic Virus Breakthrough | AcademicJobs
Tottori University researchers unveil FUVAC121, a fusogenic oncolytic vaccinia virus achieving 72% complete remission in metastatic models via immune activation.
No reviews yet. Be the first to rate Takafumi!
Professor Takafumi Nakamura serves as Professor in the Division of Genomic Medicine at the Faculty of Medicine, Tottori University. His laboratory focuses on cell and gene therapy products involving oncolytic viruses, along with research areas including cancer, gene therapy, virology, and vectors.
Tottori University researchers unveil FUVAC121, a fusogenic oncolytic vaccinia virus achieving 72% complete remission in metastatic models via immune activation.
Photo by Mufid Majnun on Unsplash
Photo by Shubham Sharan on Unsplash
Photo by Shubham Sharan on Unsplash
Photo by Evan Marvell on Unsplash
Photo by Markus Winkler on Unsplash
Photo by Patrick Robert Doyle on Unsplash
Photo by Brandi Redd on Unsplash
Have a story or a research paper to share? Become an Expert Academic Contributor and publish your work on AcademicJobs.com.
Write news and research articles as a expert academic in your field publish your work on AcademicJobs.com
